$27.43 billion. Johnson & Johnson is a global leader in medtech, having boosted its profile through the acquisition of $16.6 billion Abiomed in December 2022. The company also spun off its consumer health business with Kenvue.
Back to list
Becker's Recognition
Johnson & Johnson :has been named a Becker's honoree on the lists below.
2023 Winner
Companies
20 Medtech Companies to Know, by Revenue
Becker’s has compiled 20 medtech companies to know, most of which are working to expand their product offerings to support overall growth.
This list was created using nominations, Medical Product Outsourcing’s 2023 report, and editorial research.